Package 49702-203-18

{"route": ["ORAL"], "spl_id": "3d326658-e562-4d27-a0ad-ca2017db2e49", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "upc": ["0349702204133", "0349702203181"], "unii": ["2T8Q726O95"], "rxcui": ["152931", "152932", "199147", "199148", "349491", "352230"], "spl_set_id": ["89226149-47fa-4f7d-bb1f-1aa7034486b8"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["ViiV Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (49702-203-18)", "package_ndc": "49702-203-18", "marketing_start_date": "20101004"}], "brand_name": "EPIVIR", "product_id": "49702-203_3d326658-e562-4d27-a0ad-ca2017db2e49", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "49702-203", "generic_name": "lamivudine", "labeler_name": "ViiV Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EPIVIR", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "150 mg/1"}], "application_number": "NDA020564", "marketing_category": "NDA", "marketing_start_date": "20101004", "listing_expiration_date": "20261231"}